NEW YORK, May 31, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Oral Transmucosal Drug Delivery
http://www.reportlinker.com/p0870772/Oral-Transmucosal-Drug-Delivery.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Delivery_Technology
In their search for alternative delivery methods that will enhance compliance and improve safety, drug developers and researchers are discovering that the permeability of mucous membranes provides a convenient route for the systemic delivery of new and existing therapeutic drugs. Transmucosal delivery offers the potential for once daily dosing of oral drugs and avoids the effects of first pass metabolism. On the provider side, the development of alternative methods of drug administration has improved the ability of physicians to manage specific problems. Practitioners now recognize the rapid onset, relative reliability, and the general lack of patient discomfort when drugs are administered by the transmucosal route. We expect this market to experience healthy growth through 2015 as buccal technology is applied to existing drugs and as transmucosal formulations become an important route of administration for an increasing number of new NCEs. Growth in this sector will also be driven by the pressure to extend market protection for numerous existing drugs with soon-to-expire patents.
Highlights
• Analyzes and evaluates oral transmucosal drug delivery technology platforms and their impact on the market
• Analyzes oral transmucosal drug products and pipeline product candidates
• Provides assessments of key oral transmucosal drug therapeutic categories
• Provides market data and forecasts to 2016
• Profiles market participants, their product development activities and strategies
Executive Summary
Executive Summary
Drug Delivery Market Dynamics
Evolution in Drug Development
Market and Demand Drivers
Shifting Patient Demographics
The Impact of Generics
Managed Care Initiatives
Competitive Landscape
Competing Transmucosal Delivery Technologies
Oral Sprays
Buccal Films and Tablets
Sublingual Films and Wafers
Commercial Transmucosal Formulation Platforms
Adversa
BEMA
Bioadhesive Delivery System
Corplex
FluidCrystal
Intravail
Lauriad
OraDisc
OraVescent
RapidMist
Transmucosal Film
Oral Transmucosal Drug Technology Factors
Absorption
Bioavailability
Adhesion
Pharmacokinetics
FDA-Approved Oral Transmucosal Products
Asenapine
Buprenorphine (3 products)
Ergotamine
Fentanyl (8 products)
Hydergine
Isosorbide dinitrate (2 products)
Miconazole
Nitroglycerin (3 Products)
Ondansetron
Testosterone
Zolpidem (3 products)
Zuplenz
Important Pipeline Product Candidates
Agomelatine
ALKS 5461
Buprenorphine
Buprehorphine
Buprenorphine
Cannabinoid
Desmopressin
Fentanyl
Fentanyl
Granisetron
Insulin
Ramelteon
Sufentanil
Sumatriptan
Zolpidem
Zolpidem
Market Assessments & Forecasts
Addiction
Anti-infectives
Cardiology
Diabetes
Immunology
Infectious Disease
Neurology
Oncology
Pain Management
Sexual Health
Vaccines
Market Factors
Formulations and Proprietary Platforms
Government Regulations
Patent Expiration and Rx-to-OTC Switching
Market Participant Profiles
To order this report:
Drug Delivery Technology Industry: Oral Transmucosal Drug Delivery
Check our Industry Analysis and Insights
__________________________
Contact Nicolas: [email protected]
US: (805)-652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article